COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
HCQ study #212 of 264
12/10 Late treatment study
Alqassieh et al., F1000Research, Preprint (Preprint)
Clinical characteristics and predictors of the duration of hospital stay in COVID-19 patients in Jordan
Source   PDF   Share   Tweet
Prospective observational study of 131 COVID-19 patients in Jordan, showing 18% shorter hospital stay with HCQ, p = 0.11.

Alqassieh et al., 12/10/2020, prospective, Jordan, Middle East, preprint, 10 authors.
hospitalization time, 18.2% lower, relative time 0.82, p = 0.11, treatment 63, control 68.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 264 studies    Meta analysis
Please send us corrections, updates, or comments.